Knowledge, attitudes, and practices toward linezolid–serotonergic drug interactions: a cross-sectional study
Persistent gaps in knowledge and safe prescribing practices related to the linezolid-serotonergic interaction were identified among healthcare providers in Saudi Arabia, reflecting a broader challenge globally. These findings support the need for targeted educational interventions and institution-level policies to improve awareness, enhance patient safety, and reduce preventable harm.
Authors
- Shuroug A. Alowais (ORCID: https://orcid.org/0000-0002-3266-5774)
- Abdullah Yahya Abdullah Alzahrani (ORCID: https://orcid.org/0000-0001-5231-8932)
- Khalid Ayidh Alqahtani (ORCID: https://orcid.org/0000-0003-3106-0770)
- Sumaya N. Almohareb (ORCID: https://orcid.org/0000-0003-3392-8369)
- Atheer Aldairem (ORCID: https://orcid.org/0009-0001-0924-4672)
- Abdullah A. AlZahrani (ORCID: https://orcid.org/0000-0001-7162-0256)
- Mohammad S Shawaqfeh (ORCID: https://orcid.org/0000-0003-0469-2764)
- Khalid Bin Saleh
Institutions
- King Saud bin Abdulaziz University for Health Sciences (SA)
- King Abdullah International Medical Research Center (SA)
- National Guard Health Affairs (SA)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-11-25
- DOI
- https://doi.org/10.3389/fphar.2025.1720903
- Primary Topic
- Pharmacovigilance and Adverse Drug Reactions
- Type
- article
- Field-Weighted Citation Impact
- 0.00